Prestige Consumer Healthcare (PBH) Net Income (QoQ) (2010 - 2025)
Prestige Consumer Healthcare (PBH) Net Income (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.63% |
| Sep 30, 2025 | -11.07% |
| Jun 30, 2025 | -5.31% |
| Mar 31, 2025 | -17.87% |
| Dec 31, 2024 | 12.24% |
| Sep 30, 2024 | 10.82% |
| Jun 30, 2024 | -0.79% |
| Mar 31, 2024 | -6.76% |
| Dec 31, 2023 | -0.96% |
| Sep 30, 2023 | 0.53% |
| Jun 30, 2023 | 122.15% |
| Mar 31, 2023 | -563.04% |
| Dec 31, 2022 | 1.82% |
| Sep 30, 2022 | -7.69% |
| Jun 30, 2022 | 6.12% |
| Mar 31, 2022 | 3.73% |
| Dec 31, 2021 | 10.79% |
| Sep 30, 2021 | -21.52% |
| Jun 30, 2021 | 62.63% |
| Mar 31, 2021 | -13.11% |